EU-Projekte am UKE

EU-Projekte am UKE laufen hauptsächlich in den EU-Rahmenprogrammen für Forschung und Innovation. Daneben gibt es einige Projekte in Programmen, die von anderen EU-Generaldirektionen beaufsichtigt werden wie dem EU4Health Programm der EU Generaldirektion Gesundheit & Lebensmittelsicherheit und einige ERA-Net-Projekte.

Insgesamt laufen derzeit 65 Projekte am UKE, davon 42 Projekte in Horizon Europe, dem aktuellen EU-Rahmenprogramm für Forschung und Innovation, 10 Projekte in Horizon 2020, dem letzten EU-Rahmenprogramm für Forschung und Innovation und 13 weitere EU-Projekte.

Darunter sind 19 ERC-Grants und 4 am UKE koordinierte Projekte (Stand: 01. Juli 2025).

Anzahl der laufenden Projekte am UKEProgramm
42Horizon Europe framework programme for research and innovation
=> 15European Research Council (ERC)
=> 4Marie Sklodowska Curie Actions (MSCA)
10Horizon 2020 framework programme for research and innovation
=> 4European Research Council (ERC)
=> 1Marie Sklodowska Curie Actions (MSCA)
13Programmes from various directorate generals, for example Justice and Health

Leuchtturmprojekte am UKE

  • ERC-Grants
  • ERC-Grants

    ERC-Grants (current)

    AcronymProject titleName of researcherProgrammeProject typeDuration
    ACT-PC Actionable metabolite supplements to improve treatment response in pancreatic cancerProf. N. Gagliani
    Horizon Europe-Excellent ScienceERC-PoC05/2024-10/2025
    ADAPT Tracking adaptation of naïve T cells to distinct organs to decode organ-specific immune diseasesProf. N. GaglianiHorizon Europe-Excellent ScienceERC-CoG04/2024-03/2029
    AUTO-TARGET Antigen-specific treatments to target autoimmune kidney diseasesDr. N. TomasHorizon Europe-Excellent ScienceERC-StG04/2025-03/2030
    BRAINAMICS Neuromodulatory control of brain network dynamicsProf. S. PanzeriHorizon Europe-Excellent ScienceERC-CoG01/2025-12/2029
    BrainScape How the physical environment shapes the human brainProf. Dr. S. KühnHorizon Europe-Excellent ScienceERC-CoG07/2023-06/2028
    cICMs Causal Roles of Intrinsic Coupling Modes: an Integrated Multiscale Framework for Cognitive Network DynamicsProf. Dr. A. EngelHorizon Europe-Excellent ScienceERC-AdG07/2023-06/2028
    CombaT7 Central roles of mycobacterial type VII secretion systems in intra- and inter-kingdom warfareProf. Dr. T. MarlovitsHorizon Europe-Excellent ScienceERC-SyG04/2025-03/2031
    CureFSGS Decode and Cure primary Focal Segmental GlomerulosclerosisProf. Dr. T. HuberHorizon Europe-Excellent ScienceERC-AdG03/2025-12/2029
    DECODE Desynchronizing weak cortical fields during deep brain stimulationDr. B. SchwabHorizon Europe-Excellent ScienceERC-StG01/2024-12/2028
    DynaPLIX Dynamics of Protein-Ligand InteractionsDr. E. SchulzHorizon Europe-Excellent ScienceERC-SyG05/2023-04/2029
    EXPAT How EXPectation and ATtention shape visual information processing in the human brainDr. A. AlinkHorizon Europe – Excellent ScienceERC-CoG02/2023-01/2028
    INJURMET Impact of tissue injury induced by diagnostic biopsies and surgery on cancer metastasisProf. K. PantelH2020-Excellent ScienceERC-AdG08/2019-07/2025
    LEXSYN Lysosomal exocytosis of metastable proteins to control synaptic functionDr. K. GrochowskaHorizon Europe – Excellent ScienceERC-StG04/2025-03/2030
    MICRO-COPS Microglia Control of Physiological Brain StatesProf. T. OertnerH2020-Excellent ScienceERC-SyG06/2021-05/2027
    MRStain Non-invasive staining of tissue microstructure in temporal lobe epilepsy using in- vivo MRIDr. S. MohammadiHorizon Europe – Excellent ScienceERC-CoG07/2024-06/2029
    NO PRESSURE Regulation of the L-arginine – ADMA – Nitric Oxide (NO) Pathway in the Pulmonary Vascular Response to Hypoxia and its Role for Survival of High-Risk COPD PatientsProf. R. BögerHorizon Europe – Excellent ScienceERC-AdG11/2023-10/2028
    olfACTION A circuit perspective on olfaction – how learning and context shape the propagation of information between brain areasDr. S. BitzenhoferHorizon Europe – Excellent ScienceERC-StG01/2024-12/2028
    PainPersist Psychobiological mechanisms of pain persistenceProf. C. BüchelH2020-Excellent ScienceERC-AdG01/2021-12/2026
    REpAIR Spatio-Temporal Regulation of Inflammation and Tissue Regeneration: Studying the immune system - tissue - microbiota communication to develop targeted therapies for immune-mediated diseases and cancerProf. S. HuberH2020-Excellent ScienceERC-CoG10/2020-03/2026

    ERC-grants (past)

    AcronymProject titleName of researcherProgrammeProject typeDuration
    CAPTURE-CTC A Streptavidin Microarray Platform for Capturing of Circulating Tumor Cells from the Blood of Cancer PatientsProf. K. PantelH2020-Excellent ScienceERC-PoC06/2015-11/2016
    CTCapture_2.0 Advanced platform for profiling of therapeutic targets and functional analysis of circulating tumour cells in cancer patientsProf. K. PantelH2020-Excellent ScienceERC-PoC05/2017-10/2018
    Diet-namic From fast food to healthy diet: Adressing the dynamic molecular mechanism of sequential diet switch-induced T cell plasticity for the purpose of developing new treatments for immuno-mediated diseasesProf. N. GaglianiH2020-Excellent ScienceERC-StG12/2016-11/2022
    DISSECT Disseminating tumor cells as novel biomarkers: Dissecting the metastatic cascade in cancer patientsProf. K. PantelFP7-IdeasERC-AdG08/2011-07/2016
    DNCure Dynamic signalling networks in Diabetic Nephropathy (DN) – New avenues to a personalized therapy.Prof. T. HuberFP7-IdeasERC-CoG04/2017-01/2020
    ELIMINATE Development of strategies to eliminate cancer cells from the bone marrowProf. S. LogesH2020-Excellent ScienceERC-StG02/2018-01/2024
    F12 Factor XII and the contact system:
    cross-talk between thrombosis and inflammation
    Prof. T. RennéFP7-IdeasERC-StG11/2016-07/2019
    IL-22 and IL-22BP Identifying the immune and microbial network controlling the IL-22 – IL-22bp axis to open the doors for targeted therapiesProf. S. HuberFP7-IdeasERC-StG01/2014-12/2018
    IndivuHeart Individualized early risk assessment for heart diseasesProf. T. EschenhagenFP7-IdeasERC-AdG06/2014-05/2019
    INFOSAMPLE Information Sampling in Multiattribute ChoiceDr. K. TsetsosH2020-Excellent ScienceERC-StG12/2018-05/2024
    LIFE synapses Long-term Investigation of Functional Excitatory Synapses: Linking Plasticity, Network Wiring and Memory StorageProf. S. WiegertH2020-Excellent ScienceERC-StG04/2017-09/2022
    MESA Mechanisms of social attentionProf. M. GamerFP7-IdeasERC-StG02/2014-07/2019
    MMAF Novel multimodal approach to atrial fibrillation risk assessment and identification of targets for prevention by interdisciplinary exploitation of omics, advanced electrocardiography, and imagingProf. R. SchnabelH2020-Excellent ScienceERC-CoG01/2016-06/2021
    Multisense The merging of the senses: unterstanding multisensory experienceProf. A. EngelFP7-IdeasERC-AdG08/2011-07/2016
    PLACEBO The placebo effect – a window into the relationship between mind and bodyProf. C. BüchelFP7-IdeasERC-AdG09/2011-08/2016
    PSYCHOCELL Cellular substrate of abnormal network maturation in neuropsychiatric disordersProf. I. Hanganu-OpatzH2020-Excellent ScienceERC-CoG06/2016-11/2022
    Self-Control Take control! Towards novel training regimes enhancing inhibition and impulse control in health and psychiatric diseaseProf. S. KühnH2020-Excellent ScienceERC-StG08/2016-01/2022
    SUREPIRL Picosecond Infrared Laser for Scarfree Surgery with Preservation of the Tissue Structure and Recognition of Tissue Type and BoundariesProf. Schlüter
    Prof. Miller
    FP7-IdeasERD-AdG12/2012-11/2017
  • Coordinated projects (current)

    AcronymProject titleName of researcherProgrammeProject typeDuration
    EAST-STROKE Early treatment of Atrial fibrillation for Stroke prevention Trial in acute STROKEProf. G. ThomallaHorizon Europe-HealthRIA12/2024-11/2030
    ERN RARE-LIVER The European Reference Network in Rare Liver Disease IIIProf. A. LohseEU4Health programmeEU4H Action Grant03/2019- 09/2027
    GUIDE.MRD GUIding multi-moDal thErapies against MRD by liquid biopsiesProf. K. PantelHorizon Europe-Innovative Health InitiativeIHI JU RIA05/2023-04/2028
    PANCAID Pancreatic CAncer Initial Detection via liquid biopsyProf. K. PantelHorizon Europe-Mission CancerRIA01/2023-12/2027

    Coordinated projects (past)

    AcronymProject titleName of researcherProgrammeProject typeDuration
    A4B Analytics for BiologicsProf. H. SchlüterH2020-Excellent ScienceMSCA-ITN-ETN10/2017-03/2022
    AFFECT-EU DIGITAL, RISK-BASED SCREENING FOR ATRIAL FIBRILLATION IN THE EUROPEAN COMMUNITYProf. R. SchnabelH2020-
    Societal Challenges
    RIA01/2020-03/2024
    BiomarCaRE Biomarker for Cardiovascular Risk Assessment in EuropeProf. S. BlankenbergFP7-HealthCP-FP10/2011-03/2016
    CANCER-ID Cancer treatment and monitoring through identification of circulating tumour cells and tumour related nucleic acids in bloodProf. K. PantelFP7-IMICP01/2015-12/2019
    CEF-2017Creation of IT operational helpdesk for ERN RARE LIVER for the implementation of the Clinical Patient Management SystemProf. A. LohseINEA CEF-Telecom-eHealthCEF Action Grant11/2018-02/2020
    CEF-2018ERN Rare Liver Training and SupportProf. A. LohseINEA CEF- Telecom-eHealthCEF Action Grant09/2019-12/2022
    CEF-2020Maximising ERN RARE-LIVER capabilities – 2020-EU-IA-0131Prof. A. LohseINEA CEF – Telecom - eHealthCEF Action Grant01/2022-06/2023
    CureHLH European initiative to improve knowledge, treatment and survival of haemophagocytic syndromes in childrenProf. G. Janka-SchaubFP7-HealthCP-FP06/2008-05/2011
    DEM-CHILD A Treatment-Oriented Research Project of NCL Disorders as a Major Cause of Dementia in ChildhoodDr. A. SchulzFP7-HealthCP-FP10/2011-09/2014
    DiMoPEx Diagnosis, Monitoring and Prevention of Exposure-Related Noncommunicable DiseasesProf. L. T. BudnikH2020-COSTCOST Action05/2016-04/2017
    eSMCs Extending Sensorimotor Contingencies to CognitionProf. A. EngelFP7-ICTCP01/2011-12/2014
    EuRhythDia Chronotherapeutic lifestyle intervention for diabetes and obesity to reset the circadian rhythm and improve cardiometabolic risk in the European working populationProf. R. BögerFP7-HealthCP-FP10/2011-06/2017
    euSNN European School of Network NeuroscienceProf. A. EngelH2020-Excellent ScienceMSCA-ITN-ETN10/2019-09/2024
    MentDis_ICF65+ Prevalence, 1-year incidence and symptom severity of mental disorders in the elderly: Relationship to impairment, functioning (ICF) and service utilisationDr. S. AndreasFP7-HealthCP-FP10/2008-03/2013
    PRIORITY Prevention to Reduce Incidence Of Sexual Abuse by Reaching Individuals Concerned About Their Risk to Young PeopleProf. P. BrikenDG Home Affairs-ISFPISFP Action GRant02/2022-01/2025
    Q.RARE.LI Improving health-related quality of life in patients with rare autoimmune liver diseases by structured peer-delivered support: a transnational effec-tiveness-implementation hybrid trialProf. B. LöweEuropean Joint Programme on Rare Diseases-JTCEJP Cofund Action07/2022-06/2025
    R-LIVER
    Registry for Rare Liver DiseasesProf. C. Schramm3rd Health ProgrammeRegistry project05/2020-06/2023
    socSMCs Socialising Sensori-Motor ContingenciesProf. A. EngelH2020-FETPROACTRIA01/2015-09/2019
    TENSION Efficacy and safety of thrombectomy in stroke with extended lesion and extended time window: a randomized, controlled trialProf. G. ThomallaH2020- Societal ChallengesRIA01/2018-12/2023
    T3Net Tissue Transmigration Training NetworkProf. S. LinderFP7-PeopleMC-ITN09/2009-08/2013
    WAKE-UP Efficacy and safety of MRI-based thrombolysis in wake-up stroke: a randomised, double-blind, placebo-controlled trialProf. C. GerloffFP7-Health
    CP-IP12/2011-12/2019
  • Logos Interreg und HALRIC

Hanseatic Life Science Research Infrastructure Consortium (HALRIC)

During the past decade, significant development and investments have been made in advanced research infrastructures in the Öresund Kattegat Skagerrak (ÖKS)-Hamburg area. The facilities already provide advanced Life Science tools, but there is an untapped potential to further expand the collaboration at and around the sites, as well as cross-borders

HALRIC aims to be a springboard for innovation capacity in the ÖKS-Hamburg Life Science sector via increased access to and use of cross-border front-end technologies, instruments, expertise, and data handling solutions.

HALRIC is an EU-supported project working to bring more companies, hospitals and academic researchers together in collaborations with:

  • The large-scale infrastructures, such as MAX IV & DESY and ESS & European XFEL
  • And with cutting-edge complementary infrastructures such as cryoEM, advanced biological MS, and 7Tesla-MR.

With the infrastructure comes advanced know-how and technology for sample production and preparation. The research facilities can also be used in pre-clinical and clinical research areas, which brings the innovation potential close to the patient in the shape of potential new treatments.

Through pilot projects HALRIC will facilitate collaboration between academia, hospitals, Small and Medium-sized Enterprises (SMEs) as well as larger biotech and pharma companies and we call for research project proposals for the use of one or more research infrastructures in the HALRIC consortium.

HALRIC will also work on prototype models for handling the huge amounts of electronic data generated by such infrastructures, as well as on strengthening the Life Science ecosystems and strategic dialogues between the four countries in the project.

Lund University is lead partner for the HALRIC consortium, which includes 20 other partner organizations across Sweden, Denmark, Germany and Norway. The University Medical Centre Hamburg-Eppendorf (UKE) is among these partner organizations. The consortium constitutes the full spectrum of organizations needed for multi-disciplinary collaboration with the Life Science industry.

HALRIC is a 3-year project funded by the EU-program Interreg Öresund-Kattegat-Skagerrak, which supports joint projects in the southwest of Scandinavia that promote development of societal innovation, green economy, transportation and employment.

Calls for HALRIC cross-border research and innovation pilot project proposals

Read more about HALRIC


Your contact for HALRIC at the UKE:

Prof. Dr. rer. nat. Aymelt Itzen

Center for Experimental Medicine
Institute of Biochemistry and Signal Transduction
Phone: +49 (0) 40 7410 - 53386
Email: a.itzen@uke.de

Ansprechpartnerin

Katharina Lötzer
Dr. rer. nat.
Katharina Lötzer
  • Leitung
  • EU-Forschungsförderung
  • Schwerpunkte: ERC, Marie Curie & European Innovation Council
Standort

Campus Lehre N55 , 4. Etage, Raumnummer 04.17.1